ArticleFrontiers in cell and developmental biology2025

Retraction: miR-335 targets LRRK2 and mitigates inflammation in Parkinson's disease.

Frontiers Editorial OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.